SOFIA (Bulgaria), October 30 (SeeNews) – Bulgarian drug maker Tchaikapharma [BUL:7TH] said on Monday its net profit fell to 5.6 million levs ($3.3 million/2.9 million euro) in the first nine months of the year from 6.8 million levs in the like period of 2016.
The company’s operating revenue rose to 26.0 million levs in the January-September period from 24.8 million levs in the corresponding period of last year, Tchaikapharma said in a bourse filing.
Operating expenses increased to 19.8 million levs in the review period from 17.2 million levs the year before.
In July, Tchaikapharma increased its capital to 64.3 million levs from 55.6 million levs via a new share issue.
(1 euro = 1.95583 levs)